Supernus Announces Second Quarter 2025 Financial Results
Go back to Supernus Announces Second Quarter 2025 Financial Results| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 44.21 +0.48 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.73 | 52 Week High | $26.84 | |||
| Open | $43.82 | 52 Week Low | $9.51 | |||
| Day High | $44.37 | P/E | N/A | |||
| Day Low | $42.84 | EPS | $-2.62 | |||
| Volume | 535,753 | |||||

